IFIH1 and cancer: Furthermore, we assessed its potential as a cancer therapeutic in vivo using various mouse and human cancer cell lines, gaining mechanistic insights into how it targets mainly the Z-RNA-ZBP1 and dsRNA-MDA5 axis pathways.